Product NDC: | 0009-0066 |
Proprietary Name: | Xanax |
Non Proprietary Name: | ALPRAZOLAM |
Active Ingredient(s): | 2 mg/1 & nbsp; ALPRAZOLAM |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0009-0066 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021434 |
Marketing Category: | NDA |
Start Marketing Date: | 20030117 |
Package NDC: | 0009-0066-07 |
Package Description: | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0066-07) |
NDC Code | 0009-0066-07 |
Proprietary Name | Xanax |
Package Description | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0066-07) |
Product NDC | 0009-0066 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ALPRAZOLAM |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20030117 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | ALPRAZOLAM |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |